Please assess the completion status of the following clinical trial:

Trial Title: Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed with gender incongruence by a mental health professional and willing to start gender affirming therapy~Exclusion Criteria:~* Used hormone therapy in last 6 months,~* Pregnancy,~* Planning to have biological children in the next one year,~* HIV Additional exclusion criteria for transmen: 1) hematocrit \>50% for transmen, 2) transmen with allergy to cottonseed oil (component of intramuscular testosterone injection), 3) uncompensated heart failure, 4) renal failure Additional exclusion criteria for transwomen: 1) allergy to castor oil (component of intramuscular estradiol injection), 2) Known or suspected estrogen-dependent neoplasia, 3) Active deep vein thrombosis, pulmonary embolism or a history of these conditions, 4) Active or recent (e.g., within the past year) arterial thromboembolic disease (e.g., stroke, myocardial infarction), 5) Liver enzymes (AST or ALT) \>3 times the upper limit of normal, 6) Known or suspected pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: None

Study Arms:
- Transmen (Type: None): Subjects starting testosterone therapy as part of standard of care for gender incongruence
- transwomen (Type: None): Subjects starting estradiol therapy as part of standard of care for gender incongruence

Based on this trial design, predict the completion outcome and termination type (if applicable).